Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Clinical trial NCT07279493 · RECRUITING
Trial details
- NCT number
- NCT07279493
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-22
- Primary completion
- 2026-10-18
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.